Cargando…

Diminishing clinical impact for post-approval cancer clinical trials: A retrospective cohort study

BACKGROUND: Once a drug gets FDA approved, researchers often attempt to discover new applications in different indications. The clinical impact of such post-approval activities is uncertain. We aimed to compare the clinical impact of research efforts started after approval with those started before...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouimet, Charlotte, Bouche, Gauthier, Kimmelman, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467301/ https://www.ncbi.nlm.nih.gov/pubmed/36094914 http://dx.doi.org/10.1371/journal.pone.0274115

Ejemplares similares

Large numbers of patients are needed to obtain additional approvals for new cancer drugs: A retrospective cohort study
por: Ouimet, Charlotte, et al.
Publicado: (2023)

Patient burden and clinical advances associated with postapproval monotherapy cancer drug trials: a retrospective cohort study
por: Carlisle, Benjamin Gregory, et al.
Publicado: (2020)

Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
por: Hutchinson, Nora, et al.
Publicado: (2021)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

A Database of Drug Repurposing Clinical Trials in Oncology
por: Pantziarka, Pan, et al.
Publicado: (2021)

Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?
por: Zaidi, Asifa, et al.
Publicado: (2015)

Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study
por: Gyawali, Bishal, et al.
Publicado: (2021)

Overview of approved CAR‐T therapies, ongoing clinical trials, and its impact on clinical practice
por: Sengsayadeth, Salyka, et al.
Publicado: (2021)

How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov
por: Hutchinson, Nora, et al.
Publicado: (2022)

Scarce quality assurance documentation in major clinical trial registries for approved medicines used in post-marketing clinical trials
por: Doua, Yorokpa Joachim, et al.
Publicado: (2019)

The proportion of randomized controlled trials that inform clinical practice
por: Hutchinson, Nora, et al.
Publicado: (2022)

5579775 OVERVIEW OF THE VOXELOTOR POST-APPROVAL CLINICAL RESEARCH PROGRAM
por: Minniti, C., et al.
Publicado: (2023)

Food and Drug Administration approvals in phase 3 Cancer clinical trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Clinical trials proposed for the VA Cooperative Studies Program: Success rates and factors impacting approval()
por: Burnaska, David R., et al.
Publicado: (2021)

Factors influencing the time to ethics and governance approvals for clinical trials: a retrospective cross-sectional survey
por: Crosby, Sam, et al.
Publicado: (2023)

Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
por: Duranti, Simona, et al.
Publicado: (2021)

Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs
por: Choi, Ha Yeong, et al.
Publicado: (2023)

Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022
por: Luo, Xingxian, et al.
Publicado: (2023)

Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
por: Zou, Constance X., et al.
Publicado: (2018)

From Life in the Sea to the Clinic: The Marine Drugs Approved and under Clinical Trial
por: Cappello, Emiliano, et al.
Publicado: (2021)

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
por: Namiot, Eugenia D., et al.
Publicado: (2023)

Anticancer Drug Development: Preclinical Screening, Clinical Trials and Approval
por: Selwood, D
Publicado: (2004)

Anticancer drug development: preclinical screening, clinical trials and approval
por: Teicher, B A, et al.
Publicado: (2004)

How to get ethics committee approval for clinical trials in Turkey?
por: Ilbars, Hilal, et al.
Publicado: (2018)

Why clinical translation cannot succeed without failure
por: London, Alex John, et al.
Publicado: (2015)

Hyperbaric Oxygen Therapy Can Diminish Fibromyalgia Syndrome – Prospective Clinical Trial
por: Efrati, Shai, et al.
Publicado: (2015)

Better to be in The Placebo Arm for Trials of Neurological Therapies?
por: Kimmelman, Jonathan
Publicado: (2018)

Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases
por: Tan, Aaron C., et al.
Publicado: (2022)

Clinical development success rates and social value of pediatric Phase 1 trials in oncology
por: Wasylewski, Mateusz T., et al.
Publicado: (2020)

Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: a cohort study
por: Larochelle, Matthieu, et al.
Publicado: (2017)

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
por: Lui, Austin, et al.
Publicado: (2022)

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022)

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
por: Nishikawa, Shigeto, et al.
Publicado: (2023)

Quality evaluation of investigator‐initiated trials using post‐approval cancer drugs in Japan
por: Kondo, Shunsuke, et al.
Publicado: (2017)

Clinical Pharmacokinetics of Approved RNA Therapeutics
por: Jo, Seong Jun, et al.
Publicado: (2023)

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
por: Davis, Courtney, et al.
Publicado: (2017)

Clinical benefit of cancer drugs approved in Switzerland 2010–2019
por: Adam, Roman, et al.
Publicado: (2022)

Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives
por: Forgie, Benjamin N., et al.
Publicado: (2022)

Analysis of safety specifications in risk management plan at the time of drug approval and addition of clinically significant adverse reactions in the package insert post‐approval in Japan
por: Saito, Rieko, et al.
Publicado: (2023)

Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
por: Françoso, Alex, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_55bpqgaugkndpk65fa7p886fhn